Daratumumab – breakthrough drug in multiple myeloma therapy

Journal Title: Advances in Hygiene and Experimental Medicine - Year 2014, Vol 68, Issue

Abstract

Multiple myeloma (MM) remains incurable despite important recent advances in treatment. Over the last 2 years, an anti-CD38 monoclonal antibody daratumumab (DARA) has emerged as a breakthrough targeted therapy for patients with MM. Early-stage clinical trials have found DARA to be safe and to have encouraging clinical activity as a single agent and in combination with lenalidomide in heavily pretreated, relapsed patients in whom other novel agents (such as bortezomib, thalidomide and lenalidomide) as well as stem cell transplant has already failed. This review discusses the preclinical and clinical development of DARA, its pathophysiological basis, and its prospects for future use in MM.

Authors and Affiliations

Artur Jurczyszyn, Agata Kosmaczewska, Aleksander B. Skotnicki

Keywords

Related Articles

The role of genetic (PON1 polymorphism) and environmental factors, especially physical activity, in antioxidant function of paraoxonase*

Paraoxonase 1 ([i]PON1[/i]) is a member of a three-gene family ([i]PON1, PON2[/i], and [i]PON3[/i]). PON1 activity dominates in human plasma. It is secreted from hepatic cells and is found in the circulation bound to hig...

Inhibitory polimerazy poli(ADP-rybozy) (PARP) w terapii nowotworów z mutacjami BRCA1/2

W obecnie stosowanych terapiach przeciwnowotworowych wykorzystywane są przede wszystkim związki wprowadzające uszkodzenia do DNA. Skuteczność leczenia nowotworów uzależniona jest więc od wydajności mechanizmów związanyc...

Rola greliny i leptyny w regulacji metabolizmu węglowodanów. Część I. Grelina

Grelina jest polipeptydem wydzielanym przez komórki wydzielnicze błony śluzowej żołądka i jelit, jądro łukowate podwzgórza, a także przez komórki epsilon (ε), które znajdują się w obrębie wysp trzustkowych. Grelina odgry...

Risk factors for skin cancer development in patients after organ transplantation

Cancer has become the second most common cause of death in patients after organ transplantation. Among all cancers arising de novo after transplantation skin cancers are the most common, accounting for 95% of all skin ne...

Proteins of human milk involved in immunological processes

Human milk contains a lot of components (i.e. proteins, carbohydrates, lipids, inorganic elements) which provide basic nutrients for infants during the first period of their lives. Qualitative composition of milk compone...

Download PDF file
  • EP ID EP67528
  • DOI -
  • Views 135
  • Downloads 0

How To Cite

Artur Jurczyszyn, Agata Kosmaczewska, Aleksander B. Skotnicki (2014). Daratumumab – breakthrough drug in multiple myeloma therapy. Advances in Hygiene and Experimental Medicine, 68(), 1352-1360. https://europub.co.uk./articles/-A-67528